Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Archives

You are currently viewing the 2000 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: erythromycin stearate

« Back to Dashboard

Summary for Generic Name: erythromycin stearate

Tradenames:8
Patents:0
Applicants:13
NDAs:15
Drug Master File Entries: see list95
Therapeutic Class:Antibacterials

Clinical Trials for: erythromycin stearate

Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis
Status: Terminated Condition: Gastroparesis

Erythromycin Versus Azithromycin in Preterm Premature Rupture of Membranes
Status: Withdrawn Condition: Preterm Premature Ruptured Membranes

Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis
Status: Recruiting Condition: FAP-Familial Adenomatous Polyposis

Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin
Status: Recruiting Condition: Epidermolysis Bullosa

TMC435-TiDP16-C115 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Erythromycin and Between TMC435 and Darunavir/Ritonavir (DRV/r)
Status: Completed Condition: Hepatitis C Virus

A Study of Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function
Status: Completed Condition: Healthy; Renal Insufficiency

Intravenous Erythromycin Before Endoscopy in Patients With Variceal Bleeding: A Randomized, Double-Blind Trial
Status: Completed Condition: Variceal Bleeding

The Effect of Concomitant Administration of Erythromycin and Diltiazem on CYP3A Activity in Healthy Volunteers
Status: Completed Condition: Healthy

Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis
Status: Completed Condition: Blepharitis

Erythromycin Versus Gastric Lavage to Improve Quality of Endoscopy in Patients With Upper Gastrointestinal Bleeding
Status: Recruiting Condition: Gastrointestinal Hemorrhage; Hematemesis

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Parke Davis
ERYPAR
erythromycin stearate
Tablet; Oral062032Approved prior to Jan 1, 1982DISCNNo<disabled><disabled>
Warner Chilcott
ERYPAR
erythromycin stearate
Tablet; Oral062322Approved prior to Jan 1, 1982DISCNNo<disabled><disabled>
Zenith Goldline
ERYTHROMYCIN STEARATE
erythromycin stearate
Tablet; Oral061461Approved prior to Jan 1, 1982RXNo<disabled><disabled>
Abbott
ERYTHROCIN STEARATE
erythromycin stearate
Tablet; Oral060359Approved prior to Jan 1, 1982DISCNNo<disabled><disabled>
Barr
ERYTHROMYCIN STEARATE
erythromycin stearate
Tablet; Oral063179May 15, 1990RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc